<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Melanotan II</title><link>https://peptidescanner.com/peptides/melanotan-ii/</link><description>Versioned, source-linked PeptideScanner evidence objects for Melanotan II. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/melanotan-ii.xml" rel="self" type="application/rss+xml"/><item><title>Federal Register notice 2016-27244</title><link>https://peptidescanner.com/stories/federal-register-2016-27244/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-2016-27244:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#federal-register-2016-27244-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2016-11-14. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II.</title><link>https://peptidescanner.com/stories/pubmed-pmid-11035391-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-11035391-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-11035391-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-11-04. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>High-performance liquid chromatographic assay for the alpha-melanotropin[4,10] fragment analogue (Melanotan-II) in rat plasma.</title><link>https://peptidescanner.com/stories/pubmed-pmid-1336500-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-1336500-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-1336500-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-06-29. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>The first preparative solution phase synthesis of melanotan II.</title><link>https://peptidescanner.com/stories/pubmed-pmid-19043625-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-19043625-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-19043625-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-10-20. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery.</title><link>https://peptidescanner.com/stories/pubmed-pmid-20965250-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-20965250-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-20965250-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2016-11-25. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet.</title><link>https://peptidescanner.com/stories/pubmed-pmid-24771717-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-24771717-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-24771717-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-12-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice.</title><link>https://peptidescanner.com/stories/pubmed-pmid-26108334-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-26108334-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-26108334-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-09-29. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>The unregulated use of melanotan-II is of public health interest to Australian dermatologists.</title><link>https://peptidescanner.com/stories/pubmed-pmid-28905366-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-28905366-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-28905366-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-03-14. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Melanotan II: a possible cause of renal infarction: review of the literature and case report.</title><link>https://peptidescanner.com/stories/pubmed-pmid-31953620-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-31953620-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-31953620-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-06-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Combining MALDI mass spectrometry imaging and droplet-base surface sampling analysis for tissue distribution, metabolite profiling, and relative quantification of cyclic peptide melanotan II.</title><link>https://peptidescanner.com/stories/pubmed-pmid-32674774-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-32674774-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-32674774-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-03-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Melanotan II User Experience: A Qualitative Study of Online Discussion Forums.</title><link>https://peptidescanner.com/stories/pubmed-pmid-34464955-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-34464955-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-34464955-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-02-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists.</title><link>https://peptidescanner.com/stories/pubmed-pmid-35188390-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-35188390-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-35188390-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-03-07. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2&apos;-bis-Indole Peptide Staples: Application to Melanotan-II.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38285527-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38285527-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-38285527-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-04-08. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A comparison of HPLC and bioassay methods for plasma melanotan-II (MT-II) determination: application to a pharmacokinetic study in rats.</title><link>https://peptidescanner.com/stories/pubmed-pmid-7981427-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-7981427-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-7981427-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-10-23. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-8637402-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-8637402-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-8637402-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-07-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Systemic delivery of melanotan II through the ocular route in rabbits.</title><link>https://peptidescanner.com/stories/pubmed-pmid-9050812-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-9050812-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-9050812-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2006-04-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Determination of melanotan II in rabbit urine using solid-phase extraction sample preparation followed by reversed-phase high-performance liquid chromatography.</title><link>https://peptidescanner.com/stories/pubmed-pmid-9106033-melanotan-ii/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-9106033-melanotan-ii:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-9106033-melanotan-ii-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-08-31. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
